Clinical trial
Technology to Improve Drug Adherence and Reinforce Guideline Based Exercise Targets in Patients With Heart Failure and Diabetes Mellitus (TARGET-HFDM)
NCT02918175 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Technology to Improve Drug Adherence and Reinforce Guideline Based Exercise Targets in Patients With Heart Failure and Diabetes Mellitus (TARGET-HFDM)
- Lead sponsor
- Duke University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 2, 2017
- Completion date
- September 9, 2020
- Enrollment
- 187 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.